gms | German Medical Science

66th Annual Meeting of the German Society of Neurosurgery (DGNC)
Friendship Meeting with the Italian Society of Neurosurgery (SINch)

German Society of Neurosurgery (DGNC)

7 - 10 June 2015, Karlsruhe

Sudden headache, diplopia and loss of vision – what else should the neurosurgeon know about the clinical presentation of pituitary apoplexy?

Meeting Abstract

  • Agnieszka Grzywotz - Klinik für Neurochirurgie, Universitätsklinikum Essen
  • Lars Möller - Klinik für Endokrinologie und Stoffwechselerkrankungen, Universitätsklinikum Essen
  • Volkmar Hans - Institut für Neuropathologie, Universitätsklinikum Essen
  • Ulrich Sure - Klinik für Neurochirurgie, Universitätsklinikum Essen
  • Oliver Müller - Klinik für Neurochirurgie, Universitätsklinikum Essen
  • Ilonka Kreitschmann-Andermahr - Klinik für Neurochirurgie, Universitätsklinikum Essen

Deutsche Gesellschaft für Neurochirurgie. 66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC). Karlsruhe, 07.-10.06.2015. Düsseldorf: German Medical Science GMS Publishing House; 2015. DocMI.12.05

doi: 10.3205/15dgnc328, urn:nbn:de:0183-15dgnc3282

Published: June 2, 2015

© 2015 Grzywotz et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Objective: Sudden-onset intense headache, diplopia and visual field defects are the classic clinical features of pituitary apoplexy. Since this illness entity is deemed a medical emergency requiring neurosurgical intervention, referral to a neurosurgical unit is oftentimes effected after intracranial imaging confirms the clinical suspicion without prior endocrinological work-up. Against this background, we retrospectively assessed our own series of 31 patients with pituitary apoplexy, referred to our neurosurgical unit between 1998 and 2014 for initial presenting symptoms, histology and outcome.

Method: From our clinical information system available since 2006, we identified 29 patients treated in the neurosurgical department since then. 2 further patients were identified from our outpatient clinic at follow-up appointments. Chart records were reviewed for clinical, neuropathological and endocrinological findings.

Results: The most frequent presenting symptoms were (multiple answers possible) sudden headache (n = 17), loss of vision/visual field defects (n = 11), IIIrd nerve palsy (n = 6) and manifest Addisonian crisis (n = 3). Symptoms of Addisonian crisis were present in an additional 8 patients. Histopathology revealed 8 gonadotropinomas, 4 ACTH-immunostaining tumors, 3 prolactinomas, 3 null cell adenomas, 2 plurihormonal tumors and 1 hypophysitis. Hemorrhage/necrosis was found in 8 cases (2 histologies unavailable). In 2 patients Cushing's disease (CD) was diagnosed before the apoplexy. In one of them CD resolved afterwards, the other had a tumor recurrence years later. In 3 patients CD symptoms could be retrospectively inquired before apoplexy. 2 had anterior hypopituitarism after the apoplexy/surgery and one patient became clinically manifest with CD years later. In a further patient, prior acromegalic symptoms remitted with the apoplexy and anterior panhypopituitarism evolved instead.

Conclusions: In concordance with the literature, most patients in our study also exhibited the classic clinical symptoms of pituitary apoplexy. Addisonian crisis was present in 10% patients and must be recognized by the clinician in order to avoid potentially lethal complications. Moreover, hormonal hypersecretion of endocrine active tumors may initially cease after pituitary apoplexy, but return in the long-term. This implies that patients with pituitary apoplexy need long-term neurosurgical and endocrinological follow-ups.

Note: Oliver Müller and Ilonka Kreitschmann-Andermahr contributed equally.